Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.1K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial regulation of Lck activation at the CD8 immune synapse revealed by a FRET-Based biosensor.

Cellular and molecular life sciences : CMLS·2026
Same author

Sex-specific cardioprotective role of miR-30a-5p through estrogen-dependent mechanisms in a mouse model of heart failure.

Cardiovascular diabetology·2026
Same author

PKCϵ-mediated phosphorylation of TRPC3 channel at S712 is essential for its inactivation during inflammatory signaling.

Frontiers in immunology·2026
Same author

PTMA safeguards mitochondrial integrity to sustain metabolic function and antitumor activity of CD8 T cells.

Science immunology·2026
Same author

T cell heterogeneity in asthma pathogenesis: from immunological mechanisms to biological targeted therapies.

Frontiers in immunology·2025
Same author

The peptidyl-prolyl cis-trans isomerase, Pin1, is a regulator of the protein kinase C θ (PKCθ) catalytic activity in activated T cells.

Protein science : a publication of the Protein Society·2025

Related Experiment Video

Updated: May 1, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K

Protein kinase C-η controls CTLA-4-mediated regulatory T cell function.

Kok-Fai Kong1, Guo Fu2, Yaoyang Zhang3

  • 11] Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California, USA. [2].

Nature Immunology
|April 8, 2014
PubMed
Summary

Regulatory T (Treg) cells use the CTLA-4-PKC-η pathway to suppress tumor immunity. This pathway is crucial for Treg cell function and may be a target for cancer immunotherapy.

More Related Videos

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.5K
In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

20.1K

Related Experiment Videos

Last Updated: May 1, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on: June 22, 2016

9.5K
In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
08:20

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol

Published on: December 30, 2016

20.1K

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Signaling

Background:

  • Regulatory T (Treg) cells are vital for immune homeostasis and self-tolerance.
  • Treg cells interact with antigen-presenting cells (APCs) via an immunological synapse (IS).
  • Signaling pathways within the Treg cell IS are not fully understood.

Purpose of the Study:

  • To elucidate the signaling mechanisms governing Treg cell-mediated immune suppression at the IS.
  • To investigate the role of protein kinase C eta (PKC-η) in Treg cell function and IS signaling.
  • To identify potential therapeutic targets for enhancing Treg cell-mediated immune suppression in cancer.

Main Methods:

  • Utilized PKC-η-deficient Treg cells to assess suppressive activity in vitro and in vivo.
  • Employed phosphoproteomic and biochemical analyses to identify interacting proteins at the IS.
  • Investigated the association between CTLA-4, PKC-η, and focal adhesion complexes like GIT2-αPIX-PAK.
  • Assessed the impact of PKC-η deficiency on CD86 depletion from APCs.

Main Results:

  • PKC-η was recruited to the Treg cell IS and associated with CTLA-4.
  • PKC-η-deficient Treg cells showed impaired suppressive activity, particularly against tumor immunity.
  • A novel signaling axis involving CTLA-4-PKC-η and the GIT2-αPIX-PAK complex was identified.
  • Defective activation of this complex led to reduced CD86 depletion from APCs by Treg cells.

Conclusions:

  • The CTLA-4-PKC-η signaling axis is essential for contact-dependent Treg cell suppression.
  • This pathway plays a critical role in Treg cell-mediated suppression of tumor immunity.
  • The identified CTLA-4-PKC-η pathway represents a promising target for cancer immunotherapy strategies.